Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Circulating Levels of C1q/Tnf-Α‐Related Protein 6 (Ctrp6) in Coronary Artery Disease and Its Correlation With Inflammatory Markers Publisher



Tabatabaei SA1 ; Fadaei R2 ; Moradi N3 ; Farrokhi V4 ; Vatannejad A5 ; Afrisham R6 ; Falahat A1 ; Malekshahi F1 ; Mirahmad M7 ; Abbasi A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, Dr Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  3. 3. Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
  4. 4. Department of Hematology, Faculty of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  6. 6. Department of Clinical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Pathology, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2024


Abstract

Introduction: Circulating levels of C1q/TNF-α‐related protein 6 (CTRP6) is an adipokine that is involved in regulation of glucose and lipid metabolism, inflammation, and insulin sensitivity. However, the exact role of CTRP6 in metabolic processes remains unclear due to conflicting findings. To address current gap, we aimed to investigate the serum levels of CTRP6 in patients with coronary artery disease (CAD) and its association with inflammatory cytokines. Method: In this case-control study, the serum levels of CTRP6, interlukin-6 (IL-6), tumor necrosis factor- α (TNF-α), adiponectin, and fasting insulin were measured using enzyme-linked immunosorbent assay (ELISA) kits in a total of 176 participants, consisting of 88 CAD patients and 88 control subjects. Additionally, various anthropometric and biochemical measurements were measured and compared between cases and controls. Results: The present study found that serum levels of CTRP6 were significantly higher in the CAD group (561.3 ± 15.14) compared to the control group (429.3 ± 12.85, p < 0.001). After adjusting for age, sex, and body mass index (BMI), CTRP6 levels were found to be positively associated with the risk of CAD (p < 0.001). Correlation analysis in CAD subjects revealed a positive correlation between CTRP6 levels and BMI, systolic blood pressure (SBP), malondialdehyde (MDA), TNF-α, and IL-6, as well as a negative correlation with creatinine and total anti-oxidant capacity. Conclusion: The findings of this study provide novel evidence that elevated serum levels of CTRP6 are significantly associated with an increased risk of developing CAD. Moreover, our results indicate a correlation between CTRP6 and various risk factors for atherosclerosis. © The Author(s), under exclusive licence to Tehran University of Medical Sciences 2024.
Related Docs
View other Related Docs
1. The C1q/Tnf-Related Proteins (Ctrps) in Pathogenesis of Obesity-Related Metabolic Disorders: Focus on Type 2 Diabetes and Cardiovascular Diseases, Life Sciences (2020)
2. Circulating Levels of C1q/Tnf-Α-Related Protein 6 (Ctrp6) in Polycystic Ovary Syndrome, IUBMB Life (2020)
3. Evaluation of Changing the Pattern of Ctrp5 and Inflammatory Markers Levels in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus, Archives of Physiology and Biochemistry (2022)
4. The Circulating Levels of Ctrp1 and Ctrp5 Are Associated With Obesity Indices and Carotid Intima-Media Thickness (Cimt) Value in Patients With Type 2 Diabetes: A Preliminary Study, Diabetology and Metabolic Syndrome (2021)
5. Decreased Serum Levels of Ctrp12/Adipolin in Patients With Coronary Artery Disease in Relation to Inflammatory Cytokines and Insulin Resistance, Cytokine (2019)
6. Ctrp1 in Liver Disease, Advances in Clinical Chemistry (2017)
7. Plasma Complement C1q/Tumor Necrosis Factor-Related Protein 15 Concentration Is Associated With Polycystic Ovary Syndrome, PLoS ONE (2022)
8. Circulating Ctrp5 in Rheumatoid Arthritis: An Exploratory Biomarker Study, BMC Rheumatology (2022)
Experts (# of related papers)
View all Related Experts
Solaleh Emamgholipour (9)
Hossein Poustchi (4)
Other Related Docs
9. The Circulating Levels of Complement-Clq/Tnf-Related Protein 13 (Ctrp13) in Patients With Type 2 Diabetes and Its Association With Insulin Resistance, Clinical Laboratory (2017)
10. The Impacts of C1q/Tnf-Related Protein-15 and Adiponectin on Interleukin-6 and Tumor Necrosis Factor-Α in Primary Macrophages of Patients With Coronary Artery Diseases, Cytokine (2021)
11. Lower Circulating Levels of Ctrp12 and Ctrp13 in Polycystic Ovarian Syndrome: Irrespective of Obesity, PLoS ONE (2018)
12. Association of C1q/Tnf-Related Protein-3 (Ctrp3) and Ctrp13 Serum Levels With Coronary Artery Disease in Subjects With and Without Type 2 Diabetes Mellitus, PLoS ONE (2016)
13. The Gene Expression of Ctrp12 But Not Ctrp13 Is Upregulated in Both Visceral and Subcutaneous Adipose Tissue of Obese Subjects, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)
14. Serum C1q/Tnf-Related Protein-2 (Ctrp2) Levels Are Associated With Coronary Artery Disease, Archives of Medical Research (2020)
15. Effect of Paleolithic-Based Low-Carbohydrate Vs. Moderate-Carbohydrate Diets With Portion-Control and Calorie-Counting on Ctrp6, Asprosin and Metabolic Markers in Adults With Metabolic Syndrome: A Randomized Clinical Trial, Clinical Nutrition ESPEN (2022)
16. The Association of Circulating Levels of Complement-C1q Tnf-Related Protein 5 (Ctrp5) With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: A Case-Control Study, Diabetology and Metabolic Syndrome (2015)
17. Increased Circulating Level of Ctrp15 in Patients With Type 2 Diabetes Mellitus and Its Relation With Inflammation and Insulin Resistance, Journal of Diabetes and Metabolic Disorders (2021)
18. Higher Serum Level of Ctrp15 in Patients With Coronary Artery Disease Is Associated With Disease Severity, Body Mass Index and Insulin Resistance, Archives of Physiology and Biochemistry (2022)
19. The Circulating Ctrp13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients, PLoS ONE (2016)
20. Association of Circulating Ctrp9 With Soluble Adhesion Molecules and Inflammatory Markers in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease, PLoS ONE (2018)
21. Lower Serum Levels of Meteorin-Like/Subfatin in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus Are Negatively Associated With Insulin Resistance and Inflammatory Cytokines, PLoS ONE (2018)
22. Increased Mrna Expression of Ctrp3 and Ctrp9 in Adipose Tissue From Obese Women: Is It Linked to Obesity-Related Parameters and Mrna Expression of Inflammatory Cytokines?, Reports of Biochemistry and Molecular Biology (2020)
23. Serum Levels of C1q/Tnf-Related Protein-3 in Inflammatory Bowel Disease Patients and Its Inverse Association With Inflammatory Cytokines and Insulin Resistance, IUBMB Life (2020)
24. Circulating Level of Ctrp1 in Patients With Nonalcoholic Fatty Liver Disease (Nafld): Is It Through Insulin Resistance?, PLoS ONE (2015)
25. Serum Levels of Subfatin in Patients With Type 2 Diabetes Mellitus and Its Association With Vascular Adhesion Molecules, Archives of Physiology and Biochemistry (2020)
26. Lkb1: An Emerging Therapeutic Target for Cardiovascular Diseases, Life Sciences (2022)
27. Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders Related?, Pharmaceuticals (2023)
28. C1q/Tnf-Related Protein-1: Potential Biomarker for Early Diagnosis of Autism Spectrum Disorder, International Journal of Immunopathology and Pharmacology (2022)
29. Role of Type 2 Diabetes and Hemodialysis in Serum Adipolin Concentrations: A Preliminary Study, Hemodialysis International (2019)